Progesterone supplementation during early gestation after in vitro fertilization has no effect on the delivery rate

Fertil Steril. 2001 Feb;75(2):337-41. doi: 10.1016/s0015-0282(00)01709-x.

Abstract

Objective: To compare the delivery rate with IVF or ICSI in women who did and did not receive progesterone supplementation in the first 3 weeks after a positive hCG test result.

Design: Retrospective study.

Setting: Fertility Clinic, Rigshospitalet University Hospital, Copenhagen, Denmark.

Patient(s): 200 pregnant women who did not receive progesterone (intervention group) and 200 pregnant women who received progesterone for 3 weeks after a positive hCG result.

Intervention(s): In the study group, vaginal progesterone therapy was withdrawn on the day of positive hCG result. In the control group, treatment with progesterone, 600 mg/d, was continued for 3 weeks after a positive hCG result. Both groups received 600 mg of progesterone starting on the day of embryo replacement until testing positive for pregnancy 14 days after embryo transfer.

Main outcome measures: Delivery rate.

Result(s): The number of deliveries was 126 in the study group and 128 in the control group.

Conclusion(s): The delivery rate was the same in pregnant women who received and those who did not receive progesterone for 3 weeks after a positive hCG result. Progesterone supplementation for more than 2 weeks after embryo transfer may therefore yield no benefit in terms of pregnancy.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Chorionic Gonadotropin / analysis
  • Delivery, Obstetric
  • Embryo Transfer
  • Female
  • Fertilization in Vitro*
  • Gestational Age*
  • Humans
  • Pregnancy
  • Pregnancy Outcome*
  • Progesterone / administration & dosage*
  • Retrospective Studies
  • Sperm Injections, Intracytoplasmic

Substances

  • Chorionic Gonadotropin
  • Progesterone